Secondary Acute Myeloid Leukemia (AML), Including Therapy-Related AML, Associates with Worse Treatment Outcomes, Than De Novo AML Even After Hematopoietic Stem Cell Transplantation, and Its Unfavorable Behavior Does Not Associated with Functional Activity of p-Glycoprotein, MDR1

被引:0
|
作者
Han, Boram
Lee, Ha Yeon
Yi, Jun Ho
Jang, Jun Ho [2 ]
Kim, Kihyun [1 ]
Kim, Hee Jin [3 ]
Kim, Sun-Hee
Jung, Chul Won [2 ]
Kim, Dong Hwan [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hem Onc, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Lab Med & Genet, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:891 / 891
页数:1
相关论文
共 2 条
  • [1] MONOSOMY KARYOTYPE IN ACUTE MYELOID LEUKEMIA PREDICTS ADVERSE TREATMENT OUTCOME WITH LOW COMPLETE REMISSION RATE AND WORSE EVENT-FREE AND OVERALL SURVIVAL, AND ASSOCIATES WITH HIGH FUNCTIONAL ACTIVITY OF P-GLYCOPROTEIN, MDR1
    Hwan, K. Dong
    Ahn, H. K.
    Won, Y. W.
    Jang, J. H.
    Kim, K.
    Kim, H. J.
    Kim, S. H.
    Jung, C. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 274 - 275
  • [2] Potent Graft-Versus-Leukemia Effect After Reduced Intensity (RIC) Allogeneic Stem-Cell Transplantation (ASCT) As Post-Remission Therapy for Intermediate-Risk De-Novo Acute Myeloid Leukemia (AML) with FLT3-ITD Genotype or Wild-Type (WT) NPM1 and CEBPA without FLT3-ITD
    Laboure, Gaelle
    Dulucq, Stephanie
    Vigouroux, Stephane
    Lippert, Eric
    Pigneux, Arnaud
    Tabrizi, Reza
    Leguay, Thibaut
    Bouabdallah, Krimo
    Dilhuydy, Marie-Sarah
    Schmitt, Anna
    Marit, Gerald
    Mahon, Francois-Xavier
    Milpied, Noel
    BLOOD, 2011, 118 (21) : 1766 - 1766